Showing results (191-200 of 2,202) with videos related to
Sort By:
Pageof 221
Pharmacology, Biochemistry, and Behavior|November 1, 1988
A comparison of feeding and locomotion responses to serotonin agonists in three rat strainsC S Aulakh, J L Hill, D L MurphyProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populationsD L Murphy, L J Siever, T R InselThe British Journal of Psychiatry : the Journal of Mental Science|April 1, 1979
Platelet MAO activity and evoked potentials in the identification of subjects biologically at risk for psychiatric disordersR D Coursey, M S Buchsbaum, D L MurphyPsychiatry Research|June 8, 1999
Serotonin and externalizing behavior in young childrenR A Clarke, D L Murphy, J N ConstantinoJournal of Neural Transmission. General Section|January 1, 1995
Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicityR M Wu, D L Murphy, C C ChiuehAnnals of the New York Academy of Sciences|June 15, 1996
Suppression of hydroxyl radical formation and protection of nigral neurons by l-deprenyl (selegiline)R M Wu, D L Murphy, C C ChiuehJournal of Clinical Psychopharmacology|June 1, 1990
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agentsD L Murphy, M T Pato, T A PigottBrain Research|January 4, 1991
Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibitionJ D Newman, J T Winslow, D L MurphyClinical Pharmacology and Therapeutics|November 1, 1975
Occurrence, transport, and storage of octopamine in human thrombocytesD L Murphy, D H Cahan, P B MolinoffPsychopharmacology|April 11, 1979
Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in manD L Murphy, S Lipper, S Slater, et al.Pageof 221